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Use of whole-genome sequencing 
to trace, control and characterize 
the regional expansion of 
extended-spectrum β-lactamase 
producing ST15 Klebsiella 
pneumoniae
Kai Zhou1,3, Mariette Lokate1, Ruud H. Deurenberg1, Marga Tepper2, Jan P. Arends1, 
Erwin G. C. Raangs1, Jerome Lo-Ten-Foe1, Hajo Grundmann1, John W. A. Rossen1,* & 
Alexander W. Friedrich1,*
The study describes the transmission of a CTX-M-15-producing ST15 Klebsiella pneumoniae between 
patients treated in a single center and the subsequent inter-institutional spread by patient referral 
occurring between May 2012 and September 2013. A suspected epidemiological link between clinical 
K. pneumoniae isolates was supported by patient contact tracing and genomic phylogenetic analysis 
from May to November 2012. By May 2013, a patient treated in three institutions in two cities was 
involved in an expanding cluster caused by this high-risk clone (HiRiC) (local expansion, CTX-M-15 
producing, and containing hypervirulence factors). A clone-specific multiplex PCR was developed for 
patient screening by which another patient was identified in September 2013. Genomic phylogenetic 
analysis including published ST15 genomes revealed a close homology with isolates previously found 
in the USA. Environmental contamination and lack of consistent patient screening were identified as 
being responsible for the clone dissemination. The investigation addresses the advantages of whole-
genome sequencing in the early detection of HiRiC with a high propensity of nosocomial transmission 
and prolonged circulation in the regional patient population. Our study suggests the necessity for inter-
institutional/regional collaboration for infection/outbreak management of K. pneumoniae HiRiCs.
Klebsiella pneumoniae has emerged as an important nosocomial pathogen, known as one of the “ESKAPE” path-
ogens1. Especially, the prevalence of multi-drug resistant (MDR) K. pneumoniae increased dramatically in recent 
years. This limits efficient clinical treatment tremendously resulting in undesirable treatment outcomes.
To control the spread of drug resistance, the tracking of antimicrobial resistant microorganisms is crucial 
and has been proposed in the CDC antimicrobial resistance action plan as one of the four core actions2. Use of 
multilocus sequence typing (MLST) revealed that the population of MDR K. pneumoniae is largely oligoclonal, 
and some epidemic/endemic clones have been identified. For instance, the extended-spectrum β-lactamase 
(ESBL)-producing K. pneumoniae (ESBL-KP) mainly belong to sequence type (ST) 11, ST15, ST101, ST147, and 
ST3363–7, and a specific lineage (ST258) played a major role in dissemination of Klebsiella pneumoniae carbap-
enemases (KPC) worldwide8. With the rapid development of whole-genome sequencing (WGS), the population 
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structure of MDR pathogens can be dissected at a higher resolution level. This challenges conventional hypothe-
ses on clonal descent of K. pneumoniae.
To efficiently control and prevent the dissemination of MDR pathogens in hospital settings, the ability of early 
detection and the tracking of infected or colonized patients are crucial9. This is especially a challenge during a 
prolonged outbreak, as transmissions between patients may be caused by additional reservoirs (e.g. health-care 
workers and the environment), and/or in case different institutes and/or cities are involved in the outbreak.
In this study, we present our experience in using whole-genome sequencing and further developing an out-
break clone-specific PCR for tracing and controlling a regional and inter-institutional outbreak caused by a ST15 
CTX-M-15-KP clone between May 2012 and September 2013 in the northern part of Netherlands.
Materials and Methods
Setting. The University Medical Center Groningen (UMCG) is a 1,300-bed tertiary-care medical centre in 
the northern part of Netherlands. The rehabilitation centre is part of the university hospital but located 6-kilo-
meter away from the main centre. Most patients of the rehabilitation center were transferred from the university 
hospital. If a complication occurred or if additional treatment was required, they were admitted to or visiting the 
hospital again. Part of the medical staff worked both in the hospital and the rehabilitation center.
Patient tracking and contact tracing. At the end of August 2012, an increase of ESBL-producing K. 
pneumoniae (ESBL-KP) was observed at the UMCG and the associated rehabilitation centre. To prevent fur-
ther spread, stringent infection control measures consisting of strict patient and staff cohorting were introduced 
at both sites in August 2012. The outbreak was declared under control in September 2012. Extended infection 
control measures ended in May 2013. Patients on “high risk” wards, defined as those wards having extensive 
patient exchange with the ones where positive patients stayed, were screened for ESBL-KP once a week. Patients 
overlapping with positive patients on the ward were screened twice a week. Discharged patients who overlapped 
with positive patients between May and September 2012 were traced and retrospectively screened at home using 
a self-sampling kit. The kit contained two swabs used for the throat and rectum sampling. Instructions about how 
to use the kit were included. All patients were requested to send the kit back as soon as they took the samples. A 
case was defined as a patient infected or colonized with an ESBL-producing K. pneumoniae after 1st May 2012 
sharing the same antibiotic resistance pattern as the outbreak clone.
Screening and isolates collected in this study. Screening of ESBL-producing Enterobacteriaceae 
(ESBL-E) was performed as described previously10. Briefly, patients were screened for ESBL-E carriage using per-
ianal swabs (Eswab, Copan, Italy), and environmental screening was performed in the patient rooms (e.g. beds) 
and toilets (e.g. toilet chairs) using MW728 POLYWIPE® sponge swabs (Medical wire & equipment, Wiltshire, 
England). The swab was plated on a blood agar plate after vortexing, and the liquid Amies eluent was inoculated 
on selective tryptic soy broth with cefotaxime (0.25 mg/L) and vancomycin (8 mg/L) (TSB-VC). After 18–24 hours 
of incubation (35–37 °C), 10 μ l TSB-VC was sub-cultured on both sides of an Extended Beta-Lactamase Screening 
Agar (EbSA) plate (AlphaOmega, ‘s-Gravenhage, Netherlands). The EbSA plate consists of a split MacConkey 
agar plate containing ceftazidime (1.0 mg/L) on one side and cefotaxime (1.0 mg/L) on the other side. Both sides 
contain cloxacillin (400 mg/L) and vancomycin (64 mg/L) for inhibition of AmpC beta-lactamase-producing 
bacteria and Gram-positive bacteria, respectively. Subsequently the plates were incubated aerobically at 35 to 
37 °C for 18 to 24 hours. Species identification was performed for all oxidase negative isolates that grew on either 
side of the agar by MALDI-TOF (Bruker Daltonik GmbH, Bremen, Germany). In total, 19 K. pneumoniae iso-
lates obtained from patients (KP-1 to KP12, KP-45D, KP-33P, KP-86L, and KP-33F) and environment (KP-1E to 
KP-3E) were included in this study. The details of isolates are listed in Table 1.
Conventional testing. Phenotypic susceptibility testing was performed using the Vitek II system with card 
AST N-199 (BioMerieux, Marcy l′ Etoile, France) according to the guidelines of the manufacturer. Breakpoints 
were interpreted according to EUCAST guidelines (bacteria v4.0). MLST was performed according to the proto-
col described on the K. pneumoniae MLST website (www.pasteur.fr/mlst). The sequence type (ST) was assigned 
by the MLST database (www.pasteur.fr/mlst/Kpneumoniae.html).
WGS, de novo assembly and annotation. A total of 19 isolates were sequenced. WGS and de novo 
assembly was performed as described previously11. Isolate KP-5 was randomly selected for being scaffolded 
by mate-pair sequencing. The mate-pair DNA library was prepared using the Mate Pair Library Prep Kit v2 
(Illumina) according to the manufacturer’s instructions followed by running on the Miseq for generating 100-bp 
reads. Scaffolding was performed by SSPACE standard version 3.0 with default settings12. Further gaps within 
scaffolds were attempted to be closed using GapFiller with default settings13. The genomes were manually curated 
after performing automatic annotation on the RAST server14.
Identification of antibiotic resistance-related genes and virulence factors. Three types of 
drug-resistance genes were investigated, including acquired drug-resistance genes, genes of efflux pumps, and 
genes associated with drug resistance by specific mutations. Virulence factors studied here include adhesins, 
capsule production, iron uptake systems, nitrogen source utilization and secretion systems15,16. The acquired anti-
microbial resistance genes were identified by uploading assembled genomes to the Resfinder server v2.1 (http://
cge.cbs.dtu.dk/services/ResFinder-2.1/). The other genes relating to resistance and virulence were detected by 
using the mapping unit of CLC Genomics Workbench to map and/or by blasting assembled genomes to a pseu-
domolecule generated by concatenating a set of target genes. The capsular genotype was determined in silico by 
wzi typing17. Scaffolds with resistance-related and virulence genes were blasted against GenBank to identify their 
genetic location.
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Detection of single-nucleotide polymorphisms (SNPs). The scaffolded genome of isolate KP-5 was 
ordered and oriented relative to the finished genome K. pneumoniae PMK1 (Accession number: CP008929) via 
ABACAS18. Reads of other isolates were mapped to the rearranged KP-5 genome by CLC Genomics Workbench 
with default settings. Candidate SNPs were detected by the algorithm “Quality-based variant detection” of CLC 
Genomics Workbench. SNPs were filtered out as described previously to acquire high-quality core-genome 
SNPs9.
Core-genome phylogenetic analysis. Fragments (≥ 500 bp) shared by all genomes were collected and 
then concatenated resulting in a pseudomolecule defined as the core genome. The detected high-quality SNPs 
from outbreak isolates were used for SNP-based phylogenetic reconstruction by RAxML v7.4.219 with 1000 
bootstrap replications under the general time-reversible model with Gamma correction (GTR+ G). Assembled 
genomes and genomes retrieved from GenBank were aligned by ProgressiveMauve20. The alignment of core 
genomes was used for estimating the maximum likelihood (ML) phylogeny by RAxML v7.4.2 as mentioned 
above.
Identification of DNA signatures and development of outbreak-specific multiplex PCR. The 
core genome of outbreak isolates was blasted against our local K. pneumoniae genome database (76 genomes 
with diverse sequence types). The unique fragments were extracted and blasted against GenBank (update to 20 
October 2014). The non-match fragments not related to mobile genetic elements (e.g. phages, plasmids, and 
transposons) were considered as the DNA signatures for the outbreak clone. Primers for multiplex PCR specific 
to DNA signatures were designed by MPprimer21. All PCR-positive isolates were confirmed and further charac-
terized by WGS.
Results
Outbreak description and intervention. The suspected index patient (patient 1) had been admitted to 
a hospital in Gambia for necrotizing pancreatitis before arriving to the Netherlands and was referred from a 
regional acute care hospital to the UMCG in May 2012. As an MRSA-screening test was negative before the 
patient arrived at the UMCG patient 1 was not placed in isolation upon admission. Subsequently, the patient 
was screened for ESBL-producing Enterobacteriaceae and tested positive for ESBL-KP. The patient therefore was 
immediately put into contact isolation which implied that medical staff was required to wear a gown and gloves 
when having contact with the patient. A second patient (patient 2) stayed three days at the same ward with patient 
1 and was later found positive for an ESBL-KP during the ICU stay. Two further patients were identified (patient 
3 and 4) staying on the same ICU as patient 2. The isolates obtained from these patients had identical antibiotic 
resistance features as those of patient 1 and 2. This triggered an investigation consisting of patient tracking, con-
tact tracing and screening. Subsequently, another five patients (patient 5 to 9) sharing the same ward and facilities 
Patient ID* Location Infection site Sample Date Sample ID ST
1 University hospital Colonization† 30/05/2012 KP-1 ST15
2 University hospital Multiple sites# 03/06/2012 KP-2 ST15
3 Rehabilitation center Lower respiratory tract 26/06/2012 KP-3 ST15
4 University hospital Multiple sites# 01/07/2012 KP-4 ST15
5 Rehabilitation center Urine tract 16/07/2012 KP-5 ST15
6 Rehabilitation center Urine tract 14/08/2012 KP-6 ST15
7 Rehabilitation center Urine tract 30/08/2012 KP-7 ST15
8 Rehabilitation center Colonization† 03/09/2012 KP-8 ST15
9 Rehabilitation center Colonization† 13/09/2012 KP-9 ST15
10 Rehabilitation center Colonization† 24/11/2012 KP-10 ST15
11 University hospital Lower respiratory tract 02/05/2013 KP-11 ST15
12 University hospital Colonization† 03/09/2013 KP-12 ST15
Unrelated University hospital Colonization† 27/01/2012 KP-45D ST163
Unrelated University hospital Blood 12/08/2010 KP-33P ST15
Unrelated University hospital Blood 23/11/2012 KP-86L ST437
Unrelated University hospital Blood 01/08/2013 KP-33F ST307
Environment Rehabilitation center Bed 10/09/2012 KP-1E ST15
Environment Rehabilitation center Toilet chair 10/09/2012 KP-2E ST15
Environment University hospital Toilet chair 29/10/2013 KP-3E ST15
Table 1.  Patients and K. pneumoniae isolates involved in this study. *All isolates shared an identical 
antibiogram. They were ESBL positive and resistant to amoxicillin, amoxicillin-clavulanic-acid, cefuroxime, 
cefotaxime, ceftazidime, gentamicin, tobramycin, co-trimoxazole, ciprofloxacin, cefepime, norfloxacin, and 
trimethoprim and susceptible to imipenem, polymyxin B, cefoxitin and meropenem. #Multiple infection sites 
include blood, urine tract, lower respiratory tract, and central venous line. †Colonization was defined by positive 
cultures acquired from throat and/or rectum samples.
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with patient 3 at the rehabilitation centre were found to be positive for ESBL-KP. Supplementary Fig. S1 illustrates 
the intra-hospital patient transfer. In November 2012, an ESBL-KP was isolated from another patient (patient 10) 
staying at the same ward as patients 3 and 8 who were treated in contact isolation.
In May 2013, a patient (patient 11) admitted to the neurological ICU at the UMCG was found to carry an 
ESBL-KP phenotypically indistinguishable from the 2012 outbreak strain on admission screening. Based on the 
genomic similarity between the isolate of patient 11 and the 2012 outbreak isolates, we were able to predict the 
grade of epidemiological relatedness (see below). Patient 11 had no contact with any of the ten positive patients. 
Other patients at the neurological ICU were repeatedly screened and tested negative. Patient 11 was transferred 
from a secondary hospital in a city about 80-kilometer south of the UMCG. Further investigation revealed that 
patient 11 resided in the room where patient 6, still positive for ESBL-KP, had stayed after referral from the reha-
bilitation centre to the secondary acute care hospital. In fact, a small outbreak with 4 patients was reported but 
isolates were not available for this investigation.
In September 2013, a patient (patient 12) admitted at the UMCG was identified to carry an ESBL-KP highly 
similar to the 2012 outbreak isolates using a clone-specific PCR (see below). No positive patients were found at 
the hospital during that time. Epidemiological investigation revealed that before this admission patient 12 resided 
in a room in November 2012 where patient 1 stayed two months before.
In total, twelve patients positive for a phylogenetically highly related strain (see below) were identified by 
screening more than 120 patients from May 2012 until September 2013. Seven of them developed a clinical infec-
tion (Table 1). Figure 1 shows the most likely transmission route between the patients.
Antimicrobial susceptibility and MLST typing. The 12 isolates (KPO-1 to KPO-12) from the 12 posi-
tive patients shared identical antibiotic resistance patterns. They were ESBL positive and resistant to amoxicillin, 
amoxicillin-clavulanic-acid, cefuroxime, cefotaxime, ceftazidime, gentamicin, tobramycin, co-trimoxazole, cip-
rofloxacin, cefepime, norfloxacin, and trimethoprim.
The MLST typing results showed that all isolates were assigned to ST15 (MLST profile: 1-1-1-1-1-1-1), which 
is known as the major member of the epidemic clonal group (CG) 153.
Population genomic analysis. Phylogenetic analysis of the core genome carried out for isolates from 
patients (1–4) early during the course of the investigation revealed their isogenicity. Additional isolates from 
patients (5–10) identified through contact tracing and screening as well as isolate KP-11 from sporadic patient 11 
in 2013 all fell into the same genetic cluster (Fig. 2). The 11 isolates differed by only 7 SNPs in inter- and intragenic 
regions across the core genome (see Supplementary Table S1). Indeed, three isolates obtained from patients at the 
UMCG (KP-1, KP-2 and KP-4) and another two from patients of the rehabilitation centre (KP-6 and KP-7) were 
identical, i.e. they had no SNPs in the core genome. This phylogeny is concordant with available epidemiological 
Figure 1. Putative transmission route of the regional outbreak. The transmission route was reconstructed 
by epidemiological and genomic data (see Appendix Materials and Methods for details of reconstruction 
methods). Each node represents a patient, and an arrow indicates a possible transmission event from one 
patient to another. The blue arrow with solid line represents a direct transmission event supported by both 
epidemiological data and genetic data, the blue arrow with dash line represents an indirect transmission (e.g. 
via environment) supported by epidemiological data, and the red arrow indicates the equally parsimonious 
transmission link which cannot be resolved by neither epidemiological data nor genetic data. The inter-
institutional transfer of the patient is shown by dash line, on which the distance between institutions is 
indicated. The red star represents an outbreak at the secondary hospital, but the isolates were unavailable for our 
investigation.
www.nature.com/scientificreports/
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data. We also predicted that the 2013 isolate KP-11 was derived from the outbreak clone, and differed by 2-4 SNPs 
from available 2012 outbreak isolates (Fig. 2).
To assess the population diversity of K. pneumoniae ST15, four non-outbreak ESBL-KP isolates obtained 
before and after the outbreak period at the UMCG (Table 1), and 10 strains retrieved from GenBank (see 
Supplementary Table S2 online) were included in the phylogenetic analysis. The ST15 strains were split into 
two distinct clades (I and II). Five ST15 strains (MGH63, MGH65, MGH75, BAMC07-18 and BIDMC-33B) 
isolated in US clustered with the outbreak clone (clade I) (Fig. 2). A non-outbreak ST15 strain KP-33P isolated 
from a patient at the UMCG in 2010 was separated from the outbreak clone, but clustered tightly with an ST15 
NDM-1-producing isolate PMK1 (82 SNPs) (clade II) causing a nosocomial outbreak in Nepal 201222.Another 
non-outbreak ST437 isolate KP-86L clustered with isolates of ST11 and ST258, belonging to the epidemic clone 
group 258.
Patient screening by an outbreak-specific multiplex PCR. Three DNA signatures specific to the out-
break clone were identified. Two of them consisted of coding sequences for a hypothetical protein. The other 
one was located within the capsule biosynthesis region, which consisted of a glycosyltransferase-encoding gene. 
Primers for multiplex PCR were designed based on these three signatures (see Supplementary Table S3 online). 
To assess the discriminatory capability of the primers, we tested 35 isolates representing at least 20 different 
STs including ST15 (one isolate). The result showed that only the outbreak isolates were positive in the multi-
plex PCR, and that non-outbreak ST15 isolates can be successfully discriminated from the outbreak isolates (see 
Supplementary Fig. S2).
In September 2013, an isolate KP-12 sharing an identical antibiogram with the outbreak clone was obtained 
from patient 12 (Table 1), and was identified to belong to the outbreak clone as the outbreak-specific PCR was 
positive. In March 2015, the outbreak-specific PCR was applied to exclude the genetic relation of three isolates 
obtained from 3 patients staying at the same ward, and having a similar antibiogram as the outbreak isolates. 
Results obtained using the outbreak-specific PCR were confirmed by WGS.
Environment screening. In total, 10 of 57 environmental samples were tested positive for ESBL-KP. To 
assess the genetic relatedness between environmental and patient isolates, three environmental isolates (KP-E1, 
KP-E2, and KP-E3) were selected for WGS (Table 1). The phylogenetic analysis showed that all three isolates 
clustered with the patient isolates (Fig. 2). Isolate KP-E2 (rehabilitation centre; 2012) was indistinguishable from 
those of five patients (KP-1, KP-2, KP-4, KP-6 and KP-7), and KP-E1 (rehabilitation centre; 2012) and KP-E3 
Figure 2. Core-genome phylogenetic analysis of K. pneumoniae isolates. A maximum likelihood tree was 
constructed based on the alignments of a 4.47 Mb genome, defined as the core genome in this study. The tree 
was mid-point rooted. The size of node represents the percentage of bootstrap support, and the biggest one is 
equal to 100. Sequence types are indicated between brackets. The isolation time and resource of all ST15 strains 
are shown. The cluster of outbreak isolates is simplified as a red triangle. The non-outbreak isolates sequenced 
in this study are in blue, and the others retrieved from GenBank are in black. The inset shows the close-up 
unrooted tree of outbreak isolates, in which the patient isolates are shown in red (2012) and purple (2013), and 
the environment isolates are in green. The number of SNPs is indicated on the branches.
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(university hospital; 2013) differed by only up to 3 SNPs from all other patient isolates (see Supplementary Table 
S1 online).
Resistome. Coding sequences associated with resistance were identified to elucidate the drug-resistance 
mechanisms of outbreak-associated isolates. Table 2 shows those genes detected in the outbreak isolates. All 
outbreak isolates shared the same resistome. The ESBL gene blaCTX-M-15 and the non-ESBL gene blaSHV-28 were 
detected on the plasmid and chromosome, respectively. The detection of acquired drug-resistance genes allowed 
us to explain the phenotypical resistance profile. Further analyses identified non-synonymous SNPs in acrR 
(A165T) and ramR (G56A), resulting in an amino-acid substitution in AcrR (K55N) and RamR (A19V). These 
proteins are regulators of AcrAB-TolC and mutations in these regulators may cause overexpression of AcrAB 
resulting in MDR phenotypes23. Analysis of three well-described mutational hotspots associated with resistance 
to quinolone/fluoroquinolone showed non-synonymous nucleotide changes in gyrA and parC genes, resulting in 
amino-acid substitutions in DNA gyrase (S83F, D87A) and topoisomerase IV (S80I)24.
Virulence factors. All outbreak isolates shared the same virulence factors. Table 3 shows the virulence 
factors identified in the outbreak clone, which were highly similar with those identified in the ST15 clade II 
isolate PMK1 from Nepal. Two hypervirulence-related iron uptake systems (ABC transporter Kfu and Yersinia 
high-pathogenicity island)25, were found in the outbreak clone and PMK1 but not in the non-outbreak isolate 
KP-33P (clade II). Although both the outbreak clone and PMK1 harboured a genomic island carrying the Yersinia 
high-pathogenicity island (encoding yersiniabactin) and a type IV(A) secretion system, the island’s composi-
tions and its insertion site were rather different (see Supplementary Fig. S3). The BLASTn result suggests that 
the genomic island of the outbreak clone may have been acquired from an Escherichia coli stain ED 1a (Table 3). 
Category Genetic context Resistance phenotype
Drug-resistance gene Best Hit*(Identity)
blaTEM-1 Plasmid
Penicillins, narrow-spectrum cephalosporins, inhibitor-
sensitive 100% (JF910132)
blaOXA-1 Plasmid Penicillins, inhibitor-resistant 100% (J02967)
blaSHV-28 Chromosome
Penicillins, narrow-spectrum cephalosporins, inhibitor-
sensitive 100% (AF538324)
blaCTX-M-15 Plasmid Penicillins, extended-spectrum cephalosporins, aztreonam 100% (DQ302097)
strAB Plasmid Streptomycin 100% (AF321551, M96392)
aac(6’)-Ib-cr Plasmid Aminoglycosides, fluoroquinolones 100% (DQ303918)
aac(3)-II Plasmid Gentamicin, tobramycin, netilmicin, sisomicin 100% (JX424423)
qnrB1 Plasmid Quinolones, fluoroquinolones 100% (NG_036203.1)
sul2 Plasmid Sulfonamides 100% (GQ421466)
dfrA14 Plasmid Trimethoprim 100% (GU726917)
fosA Chromosome Fosfomycin 99% (CP009114)
tetA(A) Plasmid Tetracyclines 100% (AJ517790)
Efflux pump (familiy)
acrAB-tolC (RND)† Chromosome Aminoglycosides, beta-lactams, tigecycline, macrolides PMK1 (100%)
acrD (RND) Chromosome Aminoglycosides, deoxycholate, fusidic acid, novobiocin PMK1 (100%)
mdtABC (RND) Chromosome Deoxycholate, novobiocin, bile salt PMK1 (100%)
oqxAB (RND) Chromosome Chloramphenicol, fluoroquinolones, trimethoprim 99%/100% (CP009461)
bcr (MF) Chromosome Bicyclomycin, sulfathiazole PMK1 (100%)
emrAB (MF) Chromosome Nalidixic acid, hydrophobic compounds PMK1 (100%)
fsr (MF) Chromosome Fosmidomycin PMK1 (100%)
mdfA (kdeA) (MF) Chromosome Aminoglycosides, fluoroquinolones, chloramphenicol PMK1 (100%)
mdtG (MF) Chromosome Deoxycholate, fosfomycin PMK1 (100%)
mdtH (MF) Chromosome Enoxacin, norfloxacin PMK1 (100%)
mdtL (MF) Chromosome Chloramphenicol PMK1 (100%)
smvA(MF) Chromosome Acriflavine, quaternary ammonium compounds PMK1 (100%)
sugE (SMR) Chromosome Benzalkonium chloride, ethidium bromide PMK1 (100%)
mdtK (MATE) Chromosome Acriflavine, norfloxacin PMK1 (100%)
macAB-tolC (ABC) Chromosome Macrolides PMK1 (100%)
Gene with point 
mutation Amino-acid change
gyrA S83F, D87A Quinolones, fluoroquinolones
parC S80I Quinolones, fluoroquinolones
Table 2.  Coding sequences related to drug resistance present in the outbreak clone. *The best hit is defined 
by Blastn on http://blast.ncbi.nlm.nih.gov/Blast.cgi. All matches are K. pneumoniae with 100% coverages. †There 
was a nonsynonymous SNP causing an amino-acid substitution (K55N) in AcrR.
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As the other ST15 clade I isolates, the capsular genotype of the outbreak clone was wzi24, associated with sero-
type K24 (http://bigsdb.web.pasteur.fr/klebsiella/klebsiella.html). This was different from that of clade II isolates 
PMK1 and KP-33P, which was wzi93, associated with serotype K60 (Fig. 3).
Discussion
Controlling the dissemination of multidrug-resistant pathogens remains one of the major public health chal-
lenges in the 21st century. Here, we share our experience in managing a regional outbreak caused by a HiRiC of 
ESBL-positive K. pneumoniae ST15. This lineage has previously been implicated in hospital outbreaks world-
wide4,22,26,27. The regional and temporal dimension of this outbreak was initially unexpected but became visible 
when WGS data were compared with a locally available database. The outbreak involved patients from three insti-
tutions in two cities within an 80-km distance located in the same province of the Netherlands and may well have 
gone beyond the reach of our regional infection control capacity. The high infection rate of the outbreak clone in 
patients and the rebound of two patients a year after the start of the outbreak are indicators for the virulence and 
tenacity of this clone fulfilling the criteria of a HiRiC28–30.
The strength of WGS can be fully appreciated when considering that no obvious epidemiological association 
existed between a sporadic patient in 2013 (patient 11) and patients belonging to a transmission cluster one year 
before. A compelling degree of sequence homology consisting of 2–4 SNPs difference in the core genome between 
isolates from unrelated patients, led us to suggest a link, which was subsequently vindicated by epidemiological 
investigation. The results showed that high-resolution epidemiological typing could support infection control 




Type 1 fimbriae fimBEAICDFGHK PMK1 (100%, 99%) Chromosome
Type 3 fimbriae mrkABCDF PMK1 (100%, 100%) Chromosome
Kpa fimbriae kpaABCDE PMK1 (100%, 100%) Chromosome
Kpb-like fimbriae± kpbRABCD2 PMK1 (100%, 100%) Chromosome
Kpe fimbriae# ΔkpeA, kpeBCD PMK1 (100%, 100%) Chromosome
Kpf fimbriae kpfRABCD PMK1 (100%, 100%) Chromosome
Kpg fimbriae kpgABCD pittNDM01 (100%, 99%) Chromosome
Fim2ǂ fim2AIC, fim2D::tnpA, fimF-K PMK1 (100%, 100%) Chromosome
ECP (Mat) fimbriae ecpRABCDE PMK1 (100%, 100%) Chromosome
polysaccharide adhesin pgaABCD PMK1 (100%, 100%) Chromosome
Capsule
wzi24/K24 galF-wzc, wcaJ-ugd† (Fig. 3) ATCC 43816 KPPR1 (50%, 95%) Chromosome
Iron uptake system
Fep-ent (Enterobactin) fepA-entD, fes-entF, fepDGC, ybdA, fepB, entCEBA PMK1 (100%, 100%) Chromosome
Iuc (Aerobactin) iutA PMK1 (100%, 100%) Chromosome
IroA (Salmochelin) iroN PMK1 (100%, 100%) Chromosome
Fhu (Ferrichrome) fhuACDB PMK1 (100%, 100%) Chromosome
ABC transporter Sit (Ferrous iron) sitABCD PMK1 (100%, 100%) Chromosome
ABC transporter Eit (Iron/B12/siderophore/
hemin) eitABCD PMK1 (100%, 100%) Chromosome
ABC transporter Kfu (Ferric iron) kfuABC PMK1 (100%, 100%) Chromosome
High-pathogenicity island (Yersiniabactin) ybtPQXS, ybtA-irp2-irp1-ybtUTE-fyuA E. coli ED 1a (100%, 99%) Chromosome
Feo (Ferrous iron) feoABC PMK1 (100%, 100%) Chromosome
Hmu (Hemin/hemoprotein) hmuRSTUV PMK1 (100%, 100%) Chromosome
Nitrogen source utilization
Urease ureDCBAEFG PMK1 (100%, 100%) Chromosome
Secretion system
F-type T4SS traALEKBVCGFHNUW, trbC† JM45 plasmid p1 (100%, 99%) Plasmid
T4SS (type IVA) virB1-2, virB4-6, virB8-11, virD4 E. coli ED 1a (100%, 99%) Chromosome
T6SS impH-G, imcF, vgrG, ompA, impJ, clpV† PMK1 (100%, 100%) Chromosome
Table 3.  Coding sequences related to virulence factors present in the outbreak clone. *The best hit is defined 
by Blastn on http://blast.ncbi.nlm.nih.gov/Blast.cgi. The species name is not shown if the matches are from K. 
pneumoniae. ±The adhesin gene kpbD was replaced by a different adhesin gene kpdD2 (the gene was named 
in this study). #The subunit gene kpeA was replaced by a gene encoding Tn903 transposase. ǂ The intact gene 
cluster of this fimbriae was identified on a genomic island KpGI-5 (JN181158) of K. pneumoniae KR116. †Only 
conserved/hallmark genes are shown here.
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initiatives in unambiguously clustering patients colonized or infected with bacterial species otherwise abundant 
in clinical specimen.
We demonstrated that tailor-made diagnostic markers by identifying genomic signatures could highly 
improve the efficiency of infection control, especially for HiRiCs that may be perpetuated in health care net-
works. Indeed, the outbreak-specific PCR allowed us to rapidly and undoubtedly identify another “sporadic” 
patient (patient 12) more than one year after the start of the outbreak. Most importantly, this method enables to 
distinguish outbreak isolates from non-outbreak isolates even if they shared the same sequence type (i.e. ST15 
isolate KP-33P). These advantages facilitate the early detection of patients, which can be greatly helpful for the 
prevention of clonal spread and patient treatments.
The higher resolution of WGS is also an advantage on global-scale epidemiological typing comparing to con-
ventional methods (e.g. MLST). This greatly helps us to dissect the population structure of opportunistic bacterial 
pathogens by identifying HiRiCs, i.e. clonal lineages of particular public health importance. Recent work based 
on WGS analysis reveals that K. pneumoniae ST258, another HiRiC associated with the global dissemination KPC 
carbapenemase, is actually composed of two distinct genetic clades, which challenges conventional hypotheses 
on clonal descent31. Similarly, our study shows that the population structure of ST15 may be diverse, as two clades 
were formed by the ST15 isolates analysed. Full understanding of the ST15 genomic population structure will be 
helpful for the infection management of this HiRiC. Notably, the non-outbreak ST15 isolate KP-33P obtained in 
2010 in the UMCG clustered with a ST15 NDM-1-producing Nepali outbreak isolate PMK1 (82 SNPs), suggest-
ing that they share a common ancestor.
Noteworthy, ST15 clades I and II carried two different capsular serotypes (K24 and K60), respectively. This is 
similar as the recent finding that ST258 clades I and II were mainly differentiated by an ~215-kb region including 
cps genes31. Capsular serotypes are known to be associated with different virulence-associated traits (e.g. immune 
evasion and biofilm formation) in carbapenem-resistant K. pneumoniae32. The role of the different capsular sero-
types in the pathogenicity of ST15 should be studied in the future to allow improved risk-assessment (i.e. identify 
hypervirulence- and/or epidemic-related capsule serotypes) and novel therapy (i.e. use of anti-capsule antibod-
ies). Additionally, a Yersinia high-pathogenicity island encoding yersiniabactin was identified in the outbreak 
clone. This factor was also present in the Nepali outbreak isolate PMK1, but not in the non-outbreak ST15 isolate 
KP-33P. A recent study showed that yersiniabactin is essential for K. pneumoniae to become an effective respira-
tory pathogen33. This may be one of reasons for the high infection rate (~58.3%) observed during the outbreak 
and further suggests that the capacity to rapidly acquire virulence factors is important to become a HiRiC.
Analysis of the resistome identified a set of plasmid-borne resistance genes (blaCTX-M-15-blaTEM-1-blaOXA-1-aac 
(6′ )-Ib-cr-qnrB1) in the outbreak clone that was found in Enterbacteriaceae populations spreading throughout 
Europe34–38. Acquisition of such resistome may confer an advantage to HiRiCs, thereby stimulating their emer-
gence. Indeed, a highly similar resistome was identified in a new K. pneumoniae clone (ST1427) causing a noso-
comial outbreak in our hospital39. Therefore, active surveillance of epidemic plasmid with certain resistome will 
be helpful in preventing HiRiCs dissemination.
Our study can be useful for making appropriate intervention/prevention strategies for HiRiCs in the future. 
First of all, the capacity to contaminate the environment facilitates the dissemination of the outbreak clone. 
Therefore, complete decontaminations, including cleaning and disinfection of surfaces likely to be contaminated 
by patients (e.g. bed and toilets) are extremely important for outbreak prevention and control. Secondly, frequent 
screening of patients, especially those receiving long-term healthcare and/or extensive antibiotic treatment, is 
required for controlling and preventing transmissions. Furthermore, extensive collaboration on diagnostics and 
infection prevention within a healthcare network40,41, is important for efficient infection prevention and control. 
For this, a shared database containing information on characteristics of circulating clones and data of intra- as 
well as inter-hospital patient transfer would be of great help.
In summary, our study highlights challenges in managing the outbreak of K. pneumoniae HiRiCs, suggesting 
the necessity of frequent surveillance and inter-institutional collaborations for infection/outbreak prevention and 
control.
Figure 3. Comparison of capsular polysaccharide synthesis (cps) region identified from ST15 isolates. 
The cps regions of K. pneumoniae PMK1 and KP-33P (non-outbreak isolate of this study) were identical. The 
cps region of a ST15 strain was retrieved from GenBank. The gradients (dark to pale) of the alignment region 
represent the percentage of sequence identity between samples defined by BLASTn.
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